Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill

NCT ID: NCT00045799

Last Updated: 2019-11-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

354 participants

Study Classification

INTERVENTIONAL

Study Start Date

2002-05-31

Study Completion Date

2003-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Critically ill patients are at an increased risk of having upper gastrointestinal (GI) bleeding due to stress related mucosal damage. Cimetidine, delivered continuously through intravenous infusion, is the only drug that the FDA has approved for the prevention of upper GI bleeding in critically ill patients. The present trial is intended to assess the safety and efficacy of an omeprazole sodium bicarbonate immediate-release suspension in this indication.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This trial will be a triple-blind, double-dummy, prospective, multicenter, randomized clinical trial comparing the effectiveness of OSB-IR to the effectiveness of intravenous cimetidine in preventing upper GI bleeding at risk for SRMD.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Upper Gastrointestinal Bleeding

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Omeprazole sodium bicarbonate immediate release PWD/FS

Group Type EXPERIMENTAL

Omeprazole sodium bicarbonate immediate release PWD/FS

Intervention Type DRUG

Cimetidine IV

Group Type ACTIVE_COMPARATOR

Cimetidine IV

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Omeprazole sodium bicarbonate immediate release PWD/FS

Intervention Type DRUG

Cimetidine IV

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Exclusion Criteria

Patients will be excluded from trial participation if they meet any of the following criteria:

1. A status of "No Cardiopulmonary Resuscitation (CPR)".
2. If \>48 hours has elapsed since the patient became eligible for the trial.
3. Known history of vagotomy, pyloroplasty, gastroplasty, or any other gastric surgery.
4. Known allergy to cimetidine or omeprazole.
5. Active GI bleeding (including esophageal and gastric variceal bleeding, duodenal and gastric ulcers).
6. Significant risk of swallowing blood (i.e., severe facial trauma, oral lacerations, hemoptysis).
7. Enteral feedings for the first two days of trial drug treatment.
8. Use of an investigational drug within 30 days prior to randomization.
9. Critical/intensive care unit admission following esophageal, gastric, or duodenal surgery or trauma.
10. Known history of upper gastrointestinal lesions that are likely to bleed (e.g., esophageal or gastric varices, gastric polyps, tumors, etc. but excluding patients with gastric or duodenal ulcer disease).
11. Any medical or surgical condition that precludes administration of an oral medication (i.e., OSB-IR).
12. End stage liver disease.
Minimum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bausch Health Americas, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

PAB Clinical Research

Brandon, Florida, United States

Site Status

USF Pulmonary Research

Tampa, Florida, United States

Site Status

Protocare Trials

Austell, Georgia, United States

Site Status

Shands Hospital at the University of Florida

Gainesville, Florida, United States

Site Status

University of Florida

Gainesville, Florida, United States

Site Status

Miami VAMC

Miami, Florida, United States

Site Status

Jackson Memorial Hospital

Miami, Florida, United States

Site Status

University of Alabama at Birmingham

Birmingham, Alabama, United States

Site Status

University of South Alabama

Mobile, Alabama, United States

Site Status

Arizona Pulmonary Specialists

Phoenix, Arizona, United States

Site Status

Maricopa Medical Center

Phoenix, Arizona, United States

Site Status

Arizona Pulmonary Specialists, Ltd

Phoenix, Arizona, United States

Site Status

Scottsdale Healthcare

Scottsdale, Arizona, United States

Site Status

Alta Bates Summit Medical Center

Berkeley, California, United States

Site Status

Providence St. Joseph's Medical Center

Burbank, California, United States

Site Status

Verdugo Hills Hospital

Burbank, California, United States

Site Status

Loma Linda Medical Center

Loma Linda, California, United States

Site Status

Stanford University School of Medicine

Stanford, California, United States

Site Status

Christiana Hospital

Newark, Delaware, United States

Site Status

Wellstar Kennestone Hospital

Marietta, Georgia, United States

Site Status

Protocare - Alexian Brothers Center for Clinical Research

Elk Grove Village, Illinois, United States

Site Status

West Suburban Hospital

Oak Park, Illinois, United States

Site Status

University of Iowa Health Care

Iowa City, Iowa, United States

Site Status

Department of Medicine

Kansas City, Kansas, United States

Site Status

Medical Center of LA at New Orleans (LSU Health Sci Ctr)

New Orleans, Louisiana, United States

Site Status

Louisiana State University

Shreveport, Louisiana, United States

Site Status

Baystate Medical Center

Springfield, Massachusetts, United States

Site Status

University of Massachusetts

Worcester, Massachusetts, United States

Site Status

William Beaumont Hospital

Royal Oak, Michigan, United States

Site Status

Hennepin County Medical Center

Minneapolis, Minnesota, United States

Site Status

University of Minnesota

Minneapolis, Minnesota, United States

Site Status

Regions Hospital

Saint Paul, Minnesota, United States

Site Status

Truman Medical Center Hospital Hill

Kansas City, Missouri, United States

Site Status

St. Johns Hospital

Springfield, Missouri, United States

Site Status

Washington University School of Medicine

St Louis, Missouri, United States

Site Status

University of Nebraska

Omaha, Nebraska, United States

Site Status

Cooper Hospital/UMC

Camden, New Jersey, United States

Site Status

Trinitas Hospital

Elizabeth, New Jersey, United States

Site Status

Morristown Memorial Hospital

Morristown, New Jersey, United States

Site Status

University Hospital

Newark, New Jersey, United States

Site Status

SUNY Health Science Center

Brooklyn, New York, United States

Site Status

Winthrop University Hospital

Mineola, New York, United States

Site Status

Long Island Jewish Medical Center

New Hyde Park, New York, United States

Site Status

St. Vincent's Catholic Medical Center

New York, New York, United States

Site Status

University of Rochester Medical Center

Rochester, New York, United States

Site Status

Duke University Medical Center

Durham, North Carolina, United States

Site Status

Akron General Hospital

Akron, Ohio, United States

Site Status

The Toledo Hospital

Toledo, Ohio, United States

Site Status

Oregon Health & Science University

Portland, Oregon, United States

Site Status

Abington Memorial Hospital

Abington, Pennsylvania, United States

Site Status

University of Tennessee

Memphis, Tennessee, United States

Site Status

Vanderbilt University

Nashville, Tennessee, United States

Site Status

North Texas Affiliated Medical Group

Fort Worth, Texas, United States

Site Status

Texas Tech University Health Sciences Center

Odessa, Texas, United States

Site Status

University of Vermont

Burlington, Vermont, United States

Site Status

Pulmonary & Critical Care

Richmond, Virginia, United States

Site Status

West Virginia University Hospitals, Inc

Morgantown, West Virginia, United States

Site Status

Medical College of Wisconsin

Milwaukee, Wisconsin, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OSB-IR C03

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Gastric pH in Critically Ill Patients
NCT00590928 COMPLETED PHASE4